WallStreetZenWallStreetZen

NASDAQ: ZEAL
Zealand Pharma A Stock Ownership - Who owns Zealand Pharma A?

Open Broker Account

Insider buying vs selling

Have Zealand Pharma A insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ZEAL insiders and whales buy or sell their stock.

ZEAL Shareholders

What type of owners hold Zealand Pharma A stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Goldman Sachs Group Inc1.15%500,916$8.33MInstitution
Bank Of America Corp0.51%220,523$3.67MInstitution
Awm Investment Company Inc0.11%48,957$813.86kInstitution
Jane Street Group LLC0.05%23,976$398.58kInstitution
Morgan Stanley0.02%6,705$111.46kInstitution
Us Bancorp0.00%509$8.46kInstitution
Blackrock Inc0.00%429$7.13kInstitution
Ubs Group Ag0.00%351$5.84kInstitution
Credit Suisse Ag 10.00%285$4.74kInstitution
Wells Fargo Company0.00%100$1.66kInstitution

1 of 2

ZEAL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZEAL1.84%0.00%
MCRB66.77%33.23%Net BuyingNet Buying
SIGA29.73%70.27%Net Selling
ALVR14.40%85.60%Net BuyingNet Buying
SGMO57.25%21.37%Net SellingNet Selling

Zealand Pharma A Stock Ownership FAQ

Who owns Zealand Pharma A?

Zealand Pharma A (NASDAQ: ZEAL) is owned by 1.84% institutional shareholders, 0.00% Zealand Pharma A insiders, and 98.16% retail investors. Goldman Sachs Group Inc is the largest individual Zealand Pharma A shareholder, owning 500,916.00 shares representing 1.15% of the company. Goldman Sachs Group Inc's Zealand Pharma A shares are currently valued at $8.34M.

If you're new to stock investing, here's how to buy Zealand Pharma A stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.